Answers are grounded in this paper and cite their sources.
Glioma is a common and often aggressive malignant brain cancer for which treatment is in part dependent on the mutation status of the IDH gene. Current diagnostic methods require a biopsy and genetic analysis to obtain IDH status, which can have lengthy wait times. T, the spin–lattice relaxation in the rotating frame, has shown potential to serve as a faster, non‐invasive means of IDH1‐typing that could be implemented at clinically relevant field strengths; however, there have been few studies to date that have explored its utility. This study consisted of three groups of five mice: naïve controls, IDH1‐wild‐type glioma bearing and IDH1‐mutant glioma bearing, imaged once weekly with a T‐prepped EPI sequence. It was found that IDH1‐mutant gliomas exhibited significantly higher T values in the tumour compared with the brain, while IDH1‐wild‐type gliomas presented similar T values in the tumour and brain. T was found to be sensitive to whole‐brain changes linked to glioma and IDH status, although further investigations into the confounding effects related to T and T differences are needed. A measurement of tumour T normalised to the brain (T) was able to distinguish between IDH1‐mutant and ‐wild‐type glioma, with IDH1‐mutant mice exhibiting an average T of 29% and IDH1‐wild‐type mice having an average T of only 3%. T may thus have the capacity to serve as a non‐invasive biomarker for IDH1 typing.
No takes yet. Share an insight, caveat, or question.
Ehler et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: